TY - JOUR
T1 - Electrocardiographic Changes in Pregnant Patients With Congenital Heart Disease For the STORCC Investigators
AU - Pabon, Maria A.
AU - Misra, Amrit
AU - Gauvreau, Kimberlee
AU - Duncan, Madeline E.
AU - Conklin, Ava
AU - Economy, Katherine E.
AU - Wu, Fred M.
AU - Tadros, Thomas
AU - Valente, Anne Marie
AU - Aggarwal, Shivani R.
AU - Aldweib, Nael
AU - Alexander, Alex
AU - Alshawabkeh, Laith
AU - Anwer, Tooba Z.
AU - Barker, Nancy
AU - Reyes, Fernando Baraona
AU - Buber, Yonatan
AU - Carabuena, Jean Marie
AU - Carazo, Matthew
AU - DeZorzi, Christopher
AU - Diwanji, Vedang
AU - Drakeley, Sheila
AU - Duarte, Valeria
AU - Easter, Sarah Rae
AU - Assenza, Gabriele Egidy
AU - Gauvreau, Kimberlee
AU - Graf, Julia
AU - Gurvitz, Michelle
AU - Halpern, Daniel
AU - Harmon, Amy
AU - Hickey, Kelsey
AU - Hynes, Jenna
AU - Joyce, Caitlyn
AU - Knapp, William P.
AU - Krishna, Navya
AU - Landzberg, Michael
AU - Lippmann, Matthew
AU - Marenco, Anais
AU - Miller, Sarah E.
AU - Mullen, Mary
AU - Opotowsky, Alexander
AU - Partington, Sara
AU - Pastor, Tony
AU - Rajpal, Saraubh
AU - Ray, Anna
AU - Rodriguez-Monserrate, Carla P.
AU - Rouse, Carrie
AU - Schefter, Zoe
AU - Shafer, Keri
AU - Singh, Michael N.
AU - Schmidt, Ada C.Stefanescu
AU - Taha, Bushra
AU - Tsao, Allison L.
AU - Upadhyay, Shailendra
AU - Valle, Christopher
AU - Villegas-Keech, Sara
AU - Williams, Alexandria F.
AU - Wu, Fred
N1 - Publisher Copyright:
© 2025 The Author(s). Annals of Noninvasive Electrocardiology published by Wiley Periodicals LLC.
PY - 2025/1
Y1 - 2025/1
N2 - Background: Electrocardiograms (EKGs) are routinely performed in pregnant patients with pre-existing cardiovascular disease. However, in pregnant patients with congenital heart disease (CHD), EKG changes during gestation have not been explored. Methods: We performed a retrospective study of pregnant patients with CHD enrolled in the STORCC initiative. Patients were included if they had at least two EKGs across the perinatal period and were grouped by specific conditions: atrial septal defect (ASD), tetralogy of Fallot, congenital pulmonary stenosis, coarctation of the aorta (CoA), bicuspid aortic valve (BAV), systemic right ventricle (SRV), and Fontan circulation. EKG parameters were measured in all available EKGs by two investigators, blinded to diagnosis and time of gestation. Results: One hundred and seventy pregnant patients were included. There was a statistically significant increase in HR from pre-pregnancy to third trimester in all groups except for those with Fontan and SRV. Patients with ASD and BAV had a statistically significant increase in their QTc (ASD:13 ms, p = 0.017; BAV:7 ms, p = 0.018) during pregnancy. QRS duration was shorter (4 ms) in the third trimester for patients with ASD (p = 0.033) and CoA (p = 0.014). Despite these individual findings, EKG parameters remained within normal limits and regressed to baseline in the postpartum period. Conclusions: Patients with CHD have statistically significant EKG changes throughout pregnancy, but the values remain within normal limits. Like patients without heart disease, those with CHD increase their HR during pregnancy, except individuals with SRV and Fontan, who appear to lack capacity for physiologic HR augmentation.
AB - Background: Electrocardiograms (EKGs) are routinely performed in pregnant patients with pre-existing cardiovascular disease. However, in pregnant patients with congenital heart disease (CHD), EKG changes during gestation have not been explored. Methods: We performed a retrospective study of pregnant patients with CHD enrolled in the STORCC initiative. Patients were included if they had at least two EKGs across the perinatal period and were grouped by specific conditions: atrial septal defect (ASD), tetralogy of Fallot, congenital pulmonary stenosis, coarctation of the aorta (CoA), bicuspid aortic valve (BAV), systemic right ventricle (SRV), and Fontan circulation. EKG parameters were measured in all available EKGs by two investigators, blinded to diagnosis and time of gestation. Results: One hundred and seventy pregnant patients were included. There was a statistically significant increase in HR from pre-pregnancy to third trimester in all groups except for those with Fontan and SRV. Patients with ASD and BAV had a statistically significant increase in their QTc (ASD:13 ms, p = 0.017; BAV:7 ms, p = 0.018) during pregnancy. QRS duration was shorter (4 ms) in the third trimester for patients with ASD (p = 0.033) and CoA (p = 0.014). Despite these individual findings, EKG parameters remained within normal limits and regressed to baseline in the postpartum period. Conclusions: Patients with CHD have statistically significant EKG changes throughout pregnancy, but the values remain within normal limits. Like patients without heart disease, those with CHD increase their HR during pregnancy, except individuals with SRV and Fontan, who appear to lack capacity for physiologic HR augmentation.
KW - adult congenital heart disease
KW - congenital heart disease
KW - electrocardiogram
KW - heart rate
KW - pregnancy
UR - http://www.scopus.com/inward/record.url?scp=85214429139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85214429139&partnerID=8YFLogxK
U2 - 10.1111/anec.70037
DO - 10.1111/anec.70037
M3 - Article
C2 - 39763164
AN - SCOPUS:85214429139
SN - 1082-720X
VL - 30
JO - Annals of Noninvasive Electrocardiology
JF - Annals of Noninvasive Electrocardiology
IS - 1
M1 - e70037
ER -